08-05-2021 04:03 PM | Source: Reuters
India's Panacea Biotec to make up to 25 million doses of Sputnik V vaccine
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
BENGALURU - India's Panacea Biotec Ltd said on Thursday it had agreed to produce up to 25 million doses of the Sputnik V COVID-19 vaccine using the drug substance made by Russia's Generium.
Panacea will then supply the doses to drugmaker Dr. Reddy's Laboratories for distribution in India. (https://bit.ly/3joeloz)
Latest News
MahaYuti`s landslide win a major boost to make Mahar...
Real Estate and REITs: A Growing Investment Opportunity
India leads world in science, innovation research: M...
India`s bilateral trade with ASEAN sees 5.2 pc growt...
India sees over 226 pc surge in startup funding at $...
Trump`s ``America First`` policy could reshape inter...
Technical Outlook for the week starting November 25 ...
US private-sector activity picks up pace as firms lo...
India under Trump 2.0 could bolster its position in ...
Heavy FII selling in India to taper off soon, say ma...
